title: Clozapine-treated NMS.
authors.forename: M F
authors.initials: MF
authors.lastname: Burrell
authors.forename: C
authors.initials: C
authors.lastname: Fewster
authors.forename: E
authors.initials: E
authors.lastname: Szabadi
authors.forename: M
authors.initials: M
authors.lastname: Cashman
mesh_terms: D000328:Adult; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects; D003006:Clopenthixol / Q000008:administration & dosage / Q000009:adverse effects; D003024:Clozapine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D011352:Procyclidine / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D003006:Clopenthixol; D011352:Procyclidine; D003024:Clozapine; D002746:Chlorpromazine